Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer. [PDF]
Jiang C +9 more
europepmc +1 more source
Synergistic Combination of Tamoxifen-Tetraphenylethylene Co-Assembled Micelles and Orlistat-Induced Lipid Droplet Inhibition to Overcome Tamoxifen Resistance. [PDF]
Park JY, Lee J, Kim YY, Lee S, Kim Y.
europepmc +1 more source
SRSF5 Regulates the Expression of BQ323636.1 to Modulate Tamoxifen Resistance in ER-Positive Breast Cancer. [PDF]
Tsoi H +7 more
europepmc +1 more source
In Silico Analysis Reveals MDM2 as a Potential Target of Ursolic Acid for Overcoming Tamoxifen Resistance in Breast Cancer. [PDF]
Jati YS +3 more
europepmc +1 more source
Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer. [PDF]
Azzam HN +5 more
europepmc +1 more source
17β-Hydroxysteroid dehydrogenases 1 and 2: potential markers for breast cancer recurrence and tamoxifen resistance among premenopausal women diagnosed with breast cancer in Denmark. [PDF]
Collin LJ +15 more
europepmc +1 more source
Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR-mediated epigenetic suppression on VGLL4 by DNMT1. [PDF]
Zhai J, Jiang JF, Shi L.
europepmc +1 more source
Lycorine affects tamoxifen resistance of breast cancer via m6A-based HAGLR. [PDF]
Shi L, Jiang JF, Zhai J.
europepmc +1 more source
ATP6AP1 promotes cell proliferation and tamoxifen resistance in luminal breast cancer by inducing autophagy. [PDF]
Yan Z +7 more
europepmc +1 more source
Invasive lobular carcinoma: integrated multi-omics analysis reveals silencing of Argininosuccinate synthase and upregulation of nucleotide biosynthesis in tamoxifen resistance. [PDF]
Gupta A +10 more
europepmc +1 more source

